Does this science-driven wellness company have what it takes to improve your financial health in the public markets? On July 16th, Thorne HealthTech filed its S-1 document to the SEC with the intention of raising up to $100 million from the sale of shares through an initial public offering. While it’s unknown at recording when the IPO date will be, the company plans to list on the Nasdaq under the symbol THRN. Thorne Research (as it was originally known as) was founded in July of 1984 by Al Czap with a singular dietary supplement product. As Thorne Research grew, the company developed a reputation as an industry leader in setting the standards for making nutritional supplements. In 2010, Thorne Research merged with Diversified Natural Products, and current CEO Paul Jacobson took the helm. Then six years later, the company transitioned from a direct-to-practitioner supplement company and began selling direct to consumers. In February 2021, Thorne HealthTech merged with Onegevity to create a science-driven, vertically integrated wellness platform built to deliver best-in-class, end-to-end nutritional solutions and health intelligence. The future of health will be data-driven and wellness-centric with a guiding focus on preventive care that extends the health span of each individual. Thorne HealthTech is at the intersection of those trends and this podcast episode will breakdown what makes them unique, from its omnichannel sales strategy to vertical integration and positioning within large health trends.